Production (Stage)
CARGO Therapeutics, Inc.
CRGX
$4.37
-$0.05-1.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.50M | -45.44M | -41.91M | -44.35M | -35.81M |
| Total Depreciation and Amortization | 1.22M | 1.36M | 1.78M | 2.07M | 1.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.98M | 5.58M | 4.61M | 3.00M | 1.73M |
| Change in Net Operating Assets | 31.61M | 3.60M | -4.11M | 4.20M | 2.09M |
| Cash from Operations | -37.69M | -34.89M | -39.63M | -35.08M | -30.15M |
| Capital Expenditure | -382.00K | -630.00K | -1.07M | -1.46M | -1.29M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 223.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.42M | 28.90M | -42.34M | 5.25M | -292.67M |
| Cash from Investing | 35.04M | 28.27M | -43.18M | 3.79M | -293.96M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 38.00K | 310.00K | 402.00K | 103.35M | 26.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -25.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -488.00K | 0.00 | 0.00 | -105.00K |
| Cash from Financing | 38.00K | -178.00K | 402.00K | 103.35M | -104.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.61M | -6.80M | -82.41M | 72.06M | -324.21M |